Inactive Instrument

K Stecmcell Co Ltd Stock

003190

KR7003190006

Biotechnology & Medical Research

End-of-day quote Korea S.E.
-	-

Managers and Directors: K Stecmcell Co Ltd

Manager	Title	Age	Since
Kyeong-Ho Choi CEO	Chief Executive Officer	56	-
Eun-Jong Ban CEO	Chief Executive Officer	55	-
Jin-Han Hong IRC	Investor Relations Contact	-	-

Director	Title	Age	Since
Eun-Jong Ban BRD	Director/Board Member	55	-
Seung-Taek Lee BRD	Director/Board Member	62	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-4.83%	+2.88%	+55.87%	+69.12%	69.4B
ARGENX SE	+0.02%	+1.07%	+10.63%	+76.66%	57.24B
LONZA GROUP AG	-1.34%	+2.98%	+24.79%	+100.18%	57.62B
IQVIA HOLDINGS INC.	+2.39%	+1.60%	+28.81%	+36.90%	43.65B
BEONE MEDICINES AG	+5.75%	+10.49%	+23.11%	+108.61%	44.03B
REVOLUTION MEDICINES, INC.	+8.26%	+0.50%	+213.25%	+792.62%	38.08B
CELLTRION, INC.	-1.86%	+11.46%	+26.67%	+61.40%	36.31B
GENMAB A/S	-2.97%	-9.84%	+88.86%	+76.17%	32.61B
WUXI BIOLOGICS (CAYMAN) INC.	-2.18%	+5.68%	+36.21%	-0.69%	25.47B
Average	+0.38%	+2.24%	+56.47%	+146.77%	44.93B
Weighted average by Cap.	+0.13%	+2.44%	+52.17%	+139.03%

See all sector performances

K-STEMCELL CO., Ltd is a Korea-based company engaged in the manufacture of cell therapy products. The Company provides three categories of products: stem cells, including lipostem-femoran remedies for hip joint fracture, lipostem-DM remedies for diabetes mellitus, astrostem remedy for spinal cord injury, vascostem remedies for ischemic cardiac and cerebral infarction and cancerstem remedies for cancers; endocrine remedies for anti diabetes mellitus, growth promotion and diet, and stem cell cosmetics. It also engaged in the provision of bio safety products, including disinfectant for animals, and fashion business.

Employees

Sector

Biotechnology & Medical Research

More about the company